ADVERTISEMENT
on July 20 on allegations that he conspired with patient recruiters, telemarketing call centers, and telemedicine companies to use deceptive marketing programs and illegal kickbacks and bribes, all to generate cancer genetic (CGx) test samples that earned reimbursements that totaled from $10,000 to $20,000 per sample.
ADVERTISEMENT